Prophylactic Antibiotic Use in Transarterial Chemoembolization for Hepatocellular Carcinoma

Clinical trial NCT05654896 · UNKNOWN

Trial details

NCT number: NCT05654896
Sponsor: Nadeem Iqbal
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Antibiotic Prophylaxis

Start date: 2022-11-26
Primary completion: 2023-11-26
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.